Skip to main content
OpenTrials

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,843 public trials 821 recruiting studies
Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Piclidenoson for Treatment of COVID-19

NCT04333472

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infection, +10 more
Locations
  • II Multiprofile Hospital for Active Treatment - Sofia EAD Sofia, Bulgaria
  • IV Multiprofile Hospital for Active Treatment - Sofia EAD Sofia, Bulgaria
  • Hadassah Medical Center Jerusalem, Israel
  • Shaare Zedek Medical Center Jerusalem, Israel
View Trial Details
Completed

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

NCT03227029

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program La Jolla, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • David Geffen School of Medicine at UCLA NICHD CRS Los Angeles, California, United States
  • Univ. of Colorado Denver NICHD CRS Aurora, Colorado, United States
View Trial Details
Completed

Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects

NCT04671017

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • University Hospital Bristol and Weston NHS Foundation Trust Bristol, United Kingdom
  • Newcastle University Medical School Newcastle, United Kingdom
  • Southampton NIHR Clinical Research Facility Southampton, United Kingdom
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection.

NCT05007236

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Citizen Hospital Bangalore, India
  • Madhu Superspeciality Hospital & Research Center Bangalore, India
  • Rajalakshmi Hospital & Research Center Bangalore, India
  • Panimalar medical college hospital and research institute Chennai, India
View all 16 locations
View Trial Details

Related conditions